1. A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg. Issue 8 (8th April 2022) Authors: Seino, Yutaka; Miyoshi, Hideaki; Bosch Traberg, Heidrun; Divyalasya, T V S; Nishijima, Keiji; Terauchi, Yasuo Journal: Journal of diabetes investigation Issue: Volume 13:Issue 8(2022) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗